Literature DB >> 31299839

Prevalence of HIV Associated Neurocognitive Disorder using Modified Mini Mental State Examination and its Correlation with CD4 Counts and Anti-retroviral Therapy.

Sachin Kumar1, Dandu Himanshu2, Ruchika Tandon3, Virendra Atam4, Kamal Kishore Sawlani2, Sudhir Kumar Verma3.   

Abstract

INTRODUCTION: HIV Associated Neurocognitive Disorder (HAND) is still prevalent even in the ART (Anti-Retroviral Therapy) era. It may have some association with CD4 counts and Anti-Retroviral Therapy. The prevalence of HAND in HIV-patients, was, therefore studied in the context of ART and CD4 counts.
METHODS: Modified Mini Mental State Examination scores of 200 (65% males) HIV-positive patients and 200 controls were analyzed in the context of ART and CD4 counts.
RESULTS: Maximum number of participants were educated between 8th-12th class (89.5%), aged between 25-50 years (81.5%) and a higher proportion of males had a CD4 count <500 (69.2%) (p=0.007). Using 3MS, 21% patients (mean 76.24±1.51) and none of the controls were found to be neurocognitively impaired. Mean scores of patients with CD4 counts<500(82.54±5.58) were lesser in comparison to those of patients with CD4 counts>500 (p<0.001). Those with an ART duration of <48 months had a lower score in comparison to those with an ART duration of >72 months (p=0.005).Most decrease from maximum value was seen in similarities (48.3 %), second recall (36.1 %), repetition (33.4 %), copying two pentagons (28.3 %), read and obey (24.0 %), mental reversal (22.7 %) and first recall (21.3%) parameters of Modified Mini Mental State Examination.
CONCLUSIONS: HAND was less prevalent in the present study in comparison to past literature. CD4 counts and ART duration had an inverse association with the degree of cognitive impairment. The parameters of Modified Mini Mental State Examination showing maximum impairment may be compiled to form a short screening questionnaire. © Journal of the Association of Physicians of India 2011.

Entities:  

Mesh:

Year:  2019        PMID: 31299839

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  6 in total

1.  Prevalence and Predictors of Neurocognitive Impairment in Ethiopian Population Living with HIV.

Authors:  Mohammed Salahuddin; Md Dilshad Manzar; Hamid Yimam Hassen; Aleem Unissa; Unaise Abdul Hameed; David Warren Spence; Seithikurippu R Pandi-Perumal
Journal:  HIV AIDS (Auckl)       Date:  2020-10-13

Review 2.  The Increase of HIV-1 Infection, Neurocognitive Impairment, and Type 2 Diabetes in The Rio Grande Valley.

Authors:  Roberto De La Garza; Hansapani Rodrigo; Francisco Fernandez; Upal Roy
Journal:  Curr HIV Res       Date:  2019       Impact factor: 1.581

3.  Machine learning prediction of neurocognitive impairment among people with HIV using clinical and multimodal magnetic resonance imaging data.

Authors:  Yunan Xu; Yizi Lin; Ryan P Bell; Sheri L Towe; John M Pearson; Tauseef Nadeem; Cliburn Chan; Christina S Meade
Journal:  J Neurovirol       Date:  2021-01-19       Impact factor: 2.643

4.  Aerobic Exercise in HIV-Associated Neurocognitive Disorders: Protocol for a Randomized Controlled Trial.

Authors:  Martins Nweke; Nombeko Mshunqane; Nalini Govender; Aderonke Akinpelu; Adesola Ogunniyi
Journal:  JMIR Res Protoc       Date:  2022-01-31

5.  Fewer neurocognitive deficits and less brain atrophy by third ventricle measurement in PLWH treated with modern ART: A prospective analysis.

Authors:  Dominic Kaddu-Mulindwa; Matthias Heit; Gudrun Wagenpfeil; Moritz Bewarder; Klaus Fassbender; Stefanie Behnke; Umut Yilmaz; Mathias Fousse
Journal:  Front Neurol       Date:  2022-08-23       Impact factor: 4.086

6.  Cognitive ageing is premature among a community sample of optimally treated people living with HIV.

Authors:  H L Aung; M Bloch; T Vincent; D Quan; A Jayewardene; Z Liu; T M Gates; B Brew; L Mao; L A Cysique
Journal:  HIV Med       Date:  2020-10-21       Impact factor: 3.180

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.